TNFAIP3 gene rs7749323 polymorphism is associated with late onset myasthenia gravis
暂无分享,去创建一个
Yong-qiang Zhang | yuan zhao | P. Lei | Xiaoquan Zhu | Liang Sun | Y. Meng | Hong-wei Yang | Shuhui Wang | Yan‐chen Xie | Yun-xiao Meng
[1] Y. Li,et al. GR gene polymorphism is associated with inter‐subject variability in response to glucocorticoids in patients with myasthenia gravis , 2016, European journal of neurology.
[2] A. Marx,et al. Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis. , 2016, Clinical immunology.
[3] N. Gilhus,et al. Myasthenia gravis — autoantibody characteristics and their implications for therapy , 2016, Nature Reviews Neurology.
[4] Yaoxian Yue,et al. Myasthenia gravis: subgroup classifications , 2016, The Lancet Neurology.
[5] J. Mullikin,et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early onset autoinflammatory syndrome , 2015, Nature Genetics.
[6] Annette Lee,et al. Genome-Wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of TNFRSF11A and Identification of ZBTB10 and Three Distinct HLA Associations , 2015, Molecular medicine.
[7] Nils Erik Gilhus,et al. Myasthenia gravis: subgroup classification and therapeutic strategies , 2015, The Lancet Neurology.
[8] K. Rajesh,et al. Ocular Myasthenia Gravis: A Review. , 2015 .
[9] C. Quan,et al. The TNFAIP3 polymorphism rs610604 both associates with the risk of psoriasis vulgaris and affects the clinical severity , 2015, Clinical and experimental dermatology.
[10] Michael Benatar,et al. A genome-wide association study of myasthenia gravis. , 2015, JAMA neurology.
[11] A. Chan,et al. Association of TNFAIP3 and TNFRSF1A variation with multiple sclerosis in a German case–control cohort , 2015, International journal of immunogenetics.
[12] S. Ambika,et al. The diagnostic yield of neuroimaging in sixth nerve palsy - Sankara Nethralaya Abducens Palsy Study (SNAPS): Report 1 , 2014, Indian journal of ophthalmology.
[13] A. Marx,et al. The Association of PTPN22 R620W Polymorphism Is Stronger with Late-Onset AChR-Myasthenia Gravis in Turkey , 2014, PloS one.
[14] Liang Sun,et al. CTLA4 Variants and Haplotype Contribute Genetic Susceptibility to Myasthenia Gravis in Northern Chinese Population , 2014, PloS one.
[15] L. Catrysse,et al. A20 in inflammation and autoimmunity. , 2014, Trends in immunology.
[16] C. Ferran,et al. Single nucleotide polymorphisms at the TNFAIP3/A20 locus and susceptibility/resistance to inflammatory and autoimmune diseases. , 2014, Advances in experimental medicine and biology.
[17] Xinpeng Zhang,et al. Single nucleotide polymorphisms in TNFAIP3 were associated with the risks of rheumatoid arthritis in northern Chinese Han population , 2014, BMC Medical Genetics.
[18] Soumya Raychaudhuri,et al. Risk for myasthenia gravis maps to a 151Pro→Ala change in TNIP1 and to human leukocyte antigen‐B*08 , 2012, Annals of neurology.
[19] A. Ma,et al. A20: linking a complex regulator of ubiquitylation to immunity and human disease , 2012, Nature Reviews Immunology.
[20] Y. Lee,et al. Associations between TNFAIP3 gene polymorphisms and systemic lupus erythematosus: a meta-analysis. , 2012, Genetic testing and molecular biomarkers.
[21] S. Bae,et al. Associations between TNFAIP3 gene polymorphisms and rheumatoid arthritis: a meta-analysis , 2012, Inflammation Research.
[22] James T. Elder,et al. TNFAIP3 Gene Polymorphisms Are Associated with Response to TNF Blockade in Psoriasis , 2011, The Journal of investigative dermatology.
[23] Hai-feng Li,et al. Association between HLA-DRB1 and myasthenia gravis in a northern Han Chinese population , 2011, Journal of Clinical Neuroscience.
[24] G. van Loo,et al. Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease. , 2011, Biochemical Society transactions.
[25] P. Kwok,et al. Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseases , 2011, Genes and Immunity.
[26] D. Sanders,et al. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity , 2009, The Lancet Neurology.
[27] Pui-Yan Kwok,et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus , 2008, Nature Genetics.
[28] J. Aarli. Myasthenia Gravis in the Elderly , 2008, Annals of the New York Academy of Sciences.
[29] J. Sanders,et al. A sensitive non-isotopic assay for acetylcholine receptor autoantibodies. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[30] J. Oger. Thymus Histology and Acetylcholine Receptor Antibodies in Generalized Myasthenia Gravis , 1993, Annals of the New York Academy of Sciences.
[31] J. Oger,et al. Acetylcholine Receptor Antibodies in Myasthenia Gravis: Use of a Qualitative Assay for Diagnostic Purposes , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.